Left ventricular mass and function before and after antihypertensive treatment

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Research

Background:

• Hypertension is a major risk factor for cardiovascular disease.
• Left ventricular hypertrophy (LVH) is a common complication of uncontrolled hypertension.
• Effective blood pressure control is crucial for preventing cardiac remodeling.

Purpose of the Study:

• To investigate the impact of blood pressure control on left ventricular mass and function.
• To evaluate the efficacy of captopril, alone or in combination with chlorthalidone, in reversing LVH.
• To assess changes in left ventricular geometry and stress in hypertensive patients.

Main Methods:

• A sequential, placebo-controlled study involving 20 hypertensive patients.
• Treatment included placebo, captopril (250 mg/day), and captopril (125 mg/day) with or without chlorthalidone (25 mg/day).
• M-mode echocardiography was used to measure left ventricular mass, wall thickness, and function.

Main Results:

• Therapy significantly reduced blood pressure (p < 0.01).
• Left ventricular mass index, interventricular septal thickness, and posterior wall thickness significantly decreased (p < 0.001 at 16 weeks).
• Left ventricular function remained unchanged, but wall stress indices were significantly lowered.

Conclusions:

• Captopril, with or without chlorthalidone, effectively reduces left ventricular mass in hypertensive patients.
• The treatment reverses left ventricular hypertrophy by decreasing septal and posterior wall thickness.
• Blood pressure control is key to normalizing cardiac structure in uncomplicated hypertension.